Contrarian Investing- JNJ Again
I originally mentioned these types of investments 3 years ago with good ol' Johnson & Johnson. Now with the pause on its vaccine, it looks like I may get a third or fourth go-around with the same company. It was $50 cheaper back in July, 2018. Looks to be another opportunity to use JNJ after the stock takes a hit for the pause in their vaccine. Conversely, Pfizer and Moderna may benefit, even though initially they make take a hit also.
__________________
One of the downsides of the Internet is that it allows like-minded people to form communities, and sometimes those communities are stupid.
|